In 2004, Xeotron was acquired by Invitrogen. Xeotron manufactures flexible, high-performance and cost-effective BioChips (microarrays) based on its proprietary platform technologies that encompass PhotoGenerated Reagent (PGR) chemistry, Digital Photolithography and microfluidics technology